Oxis Intl Inc (OXIS) 0.0370 $OXIS
Oxis Biotech Inc. Announces Resumption of Trading of Common Stock on Euronext Paris
PR Newswire - Fri Apr 10, 6:30AM CDT
Oxis International, Inc. (OXIS) (OXI.PA), a biotechnology company focused on cancer therapy development and commercialization, announced today that trading in its common stock will resume on Euronext Paris on April 14, 2015. Upon resumption of trading, the shares will trade in a double call auction trading mode (fixing) rather than the continuous trading mode formerly applicable to Oxis shares.
Oxis Biotech Discusses Its Immunotherapeutic Development Strategy
PR Newswire - Wed Apr 01, 6:30AM CDT
Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc. [OTC: OXIS] discussed during its March 31, 2015 conference call with shareholders, analysts and other interested parties certain aspects of its immunotherapeutic development strategy. During the teleconference, Anthony J. Cataldo, Chairman and Chief Executive Officer stated that Oxis Biotech is focused on developing immunotherapies for the treatment of triple-negative breast cancer, and multiple myeloma and associated osteolytic lesions which are significant unmet medical needs.
Oxis International Inc. Announces Request for Euronext Trading Suspension
PR Newswire - Tue Mar 31, 8:07AM CDT
Oxis International, Inc. (OXIS) (OXI.PA) a biotechnology company focused on biotech cancer therapy development and commercialization, announced today Oxis CEO Tony Cataldo has requested a suspension of the trading of Oxis common shares on the Euronext exchange. Oxis shares will continue to trade on the OTCQB under the symbol OXIS.
MarijuanaStocks.com to Host Oxis International (OXIS) Conference Call with CEO Tony Cataldo
ACCESSWIRE - Mon Mar 30, 11:38AM CDT
CORAL GABLES, FL / ACCESSWIRE / March 30, 2015 / MarijuanaStocks.com-Oxis International (OTCQB: OXIS) recently announced that the Company will be holding an investor conference call on Tuesday, March 31, 2015 at 4:15pm EST to discuss recent corporate developments. As a result of receiving emails and social media messages from our loyal followers as to who will be hosting the conference call and how attendees can ask specific questions, MatrijuanaStocks.com reached out to OXIS CEO Tony Cataldo and expressed the amount of interest our followers have in the upcoming conference call.
Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh
PR Newswire - Thu Mar 26, 6:30AM CDT
Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc. [OTC: OXIS] and [Euronext Paris: OXI.PA] announced today the execution of an exclusive option agreement with the University of Pittsburgh related to certain patents/intellectual properties developed by Dr. Xiang-Qun Xie, Associate Dean for Research Innovation and Professor, Pharmaceutical Sciences, School of Pharmacy. These patents/intellectual properties relate to novel compositions-of-matter which could prove useful as therapeutics for the treatment of various human diseases. The term of the exclusive option is eighteen (18) months. During the term of exclusivity, the University of Pittsburgh will not offer third parties the opportunity to license these intellectual properties.
Biotechnology And The Road To Innovation: What Companies Are Pushing New Innovation In Today's Market?
ACCESSWIRE - Thu Mar 19, 8:15AM CDT
CORAL GABLES, FL / ACCESSWIRE / March 19, 2015 / Globally, the market for biotechnology has been growing at a rate of over 10% annually according to a report from IBISWorld. Annual revenue is on the cusp of breaking $290 Billion and has many sub sectors contributing to its further expansion. Industry firms have thrived as technological advances have facilitated new discoveries and ignited higher demand from firms in the pharmaceuticals and agricultural sectors. According to the report, industry growth is forecast to continue "skyrocketing in the next five-year period" where investment in biotechnology from around the world increases, particularly from emerging economies.
Rapidly Rising: Fastfunds Financial Corporation (OTCBB:FFFC)
ACCESSWIRE - Tue Mar 17, 11:55PM CDT
WINDSOR, ON / ACCESSWIRE / March 18, 2015 / The Cannabis Capitalist, an Investment newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known stocks in the new recreational and medical Cannabis industry, would like to announce a new Company which is creating excitement on Wall Street: Fastfunds Financial (OTCBB:FFFC).
CARA: 10.93 (+0.27), GWPH: 91.32 (+0.38)
MultiCell inks R&D agreement with Oxis Biotech
Seeking Alpha - at Seeking Alpha - Fri Mar 13, 12:10PM CDT
Oxis Biotech Licenses Rights To Antibody-Drug Conjugates For The Treatment Of Cancer
PR Newswire - Thu Mar 12, 6:30AM CDT
Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc. [OTC: OXIS] and [Euronext Paris: OXI.PA] announced today the execution of a definitive licensing and development agreement with MultiCell Immunotherapeutics, Inc. (MCIT) concerning the development of certain antibody-drug conjugates (ADCs). These ADCs are thought to be useful for the treatment of triple-negative breast cancer, and multiple myeloma and associated osteolytic lesions which are significant unmet medical needs.
Penny Stocks Trending Alerts for Eventure Interactive, Telupay International, TOTALLY HEMP CRAZY, OXIS International, Monster Arts, and BE ACTIVE HOLDINGS
PR Newswire - Mon Mar 09, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Eventure Interactive (OTCBB:EVTI), Telupay International (OTCMKTS:TLPY), TOTALLY HEMP CRAZY (OTCMKTS:THCZ), OXIS International (OTCMKTS:OXIS), Monster Arts (OTCBB:APPZ), and BE ACTIVE HOLDINGS (OTCMKTS:JALA).
48 Marijuana Stocks - A Post-Mortem: Part II
Anthony Cataldo - at Seeking Alpha - Wed Mar 04, 7:36AM CST
INSY: 57.97 (+0.06), FULL: 3.55 (-0.03), CARA: 10.93 (+0.27)
Top 5 Cannabis Stocks to Watch in 2015
ACCESSWIRE - Wed Feb 11, 8:39AM CST
CORAL GABLES, FL / ACCESSWIRE / February 11, 2015 / It's been a long and rough road for a push toward universal legalization of marijuana in the US. Since the early beginnings in California many decades ago with medical marijuana to the latest trail being blazed from states like Colorado, Oregon, Washington, and Alaska, this has certainly become a growth driven marketplace full of opportunity. It seems like those entering the space are facing the "kid in a candy store" mentality as so many industry assets can be applied to this new sector. From consulting services to biotech, there is a myriad of options for companies to focus on during these early stages. But the question remains, "Are 'pot' stocks really delivering for investors?" So, which stocks should you be in right now?
Oxis Biotech Inc. Provides Update for P62-ZZ Multiple Myeloma Patent Application
PR Newswire - Wed Feb 04, 6:30AM CST
Oxis International, Inc. (OXIS) (OXI.PA) a biotechnology company focused on cannabinoid therapy development and commercialization, provided today an update on its P62-ZZ Chemical Inhibitor and Therapeutic Potential for Multiple Myeloma patent application for shareholders and other interested parties.
Fresh Press Coming From Several Cannabis Related Companies
ACCESSWIRE - Mon Feb 02, 7:30AM CST
MIAMI, FL / ACCESSWIRE / February 2, 2015 / There are many things that can have an impact on share volume. These include speculation, rumors, and actual material events. Over the last week, several cannabis related public companies have made announcements which may or may not have sparked increases in trading activities for Oxis International (OTCQB:OXIS), Electronic Cigarettes International Group, Ltd. (OTCQB:ECIG), and American Green, Inc. (OTC:ERBB).
Are You Cashing In On Cannabis With These Market Movers?
ACCESSWIRE - Thu Jan 29, 9:26AM CST
MIAMI, FL / ACCESSWIRE / January 29, 2015 / The cannabis space is slowly starting to shake off its "dark cloud". The industry is now open to bigger investment, more states have legalized the drug both for medical and recreational use, and even more are putting the wheels in motion for the 2016 ballot. Here are some of the more popular movers in the sector which have been gaining attention in 2015.
This Is Where The Investment Opportunity Is Right Now In Cannabis
Small Cap Reporter - at Seeking Alpha - Tue Jan 20, 11:25AM CST
INSY: 57.97 (+0.06), GWPH: 91.32 (+0.38)
Are These Cannabis Stocks In Your Winning Portfolio Right Now?
ACCESSWIRE - Tue Jan 20, 7:31AM CST
CORAL GABLES, FL / ACCESSWIRE / January 20, 2015 / Medical marijuana has been legalized in 23 states and the District of Columbia. Recreational marijuana is now legal in two states: Colorado and Washington. The market for legalized marijuana will grow by 64% between 2014 and 2015, cites State of Marijuana Markets, "Cannabis is one of the fastest-growing industries," Steve Berg tells The Huffington Post, "domestically, we weren't able to find any market that is growing as quickly."
Cannabusiness Takes Center Stage As Stocks Rally
ACCESSWIRE - Fri Jan 16, 7:51AM CST
CORAL GABLES, FL / ACCESSWIRE / January 16, 2015 / Recreational cannabis, federal government easement on policy, and increase support from the masses has propelled massive industry growth for cannabis companies this year. Investors have found that there have been many opportunities to turn a profit during these very early stages of this industry boom. As the market continues to grow and the hopes of a less risk filled sector arise, investors continue to look for opportunity as more companies join the marijuana revolution. According to MMJ Business Daily, 2015 is expected not only to see more investment dollars flow into the market but it could even outpace the growth rate seen in 2014. The reason? States like Nevada, Illinois, Massachusetts, Oregon, and Alaska have all been identified as industry drivers this year. Furthermore, the rise in "BIG MONEY" from some major investment funds has just started to hit the marijuana sector.
Cannabis Companies Are Back In The Spotlight For 2015 On Surging Volume & Big Announcements
ACCESSWIRE - Thu Jan 15, 7:53AM CST
CORAL GABLES, FL / ACCESSWIRE / January 15, 2015 / The cannabis industry has truly evolved through its first year of legalization. We've seen the good, bad, and ugly put so much pressure on the industry that investors have become incredibly savvy in terms of diligence prior to "jumping in the pool". Once a taboo marketplace is now attracting some major investments. Not only did Paypal co-founder Peter Thiel's Founders Fund invest in the industry but now we're seeing some of the big name, pro-cannabis celebrities continue to break down barriers and put their money into the market. Tommy Chong, the Marley family, and even successful Wall Street investors like George Soros are all putting up the "dough" for full legalization of cannabis in the US. With that, many cannabis companies have found a new momentum stride as the industry may be seeing its second boom.
Oxis Biotech Inc. Announces Appointment of Dr. James J Mulé to Scientific Advisory Board
PR Newswire - Thu Jan 15, 6:30AM CST
Oxis International, Inc. (OXIS) (OXI.PA) a biotechnology company focused on cannabinoid therapy development and commercialization, announced today, Dr. James J Mulé has joined the Scientific Advisory Board for its' wholly owned subsidiary, Oxis Biotech, Inc.
Oxis Biotech Inc. Announces Resumption of Trading of Common Stock on Euronext Paris
PR Newswire - Fri Apr 10, 6:30AM CDT
Oxis International, Inc. (OXIS) (OXI.PA), a biotechnology company focused on cancer therapy development and commercialization, announced today that trading in its common stock will resume on Euronext Paris on April 14, 2015. Upon resumption of trading, the shares will trade in a double call auction trading mode (fixing) rather than the continuous trading mode formerly applicable to Oxis shares.
Oxis Biotech Discusses Its Immunotherapeutic Development Strategy
PR Newswire - Wed Apr 01, 6:30AM CDT
Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc. [OTC: OXIS] discussed during its March 31, 2015 conference call with shareholders, analysts and other interested parties certain aspects of its immunotherapeutic development strategy. During the teleconference, Anthony J. Cataldo, Chairman and Chief Executive Officer stated that Oxis Biotech is focused on developing immunotherapies for the treatment of triple-negative breast cancer, and multiple myeloma and associated osteolytic lesions which are significant unmet medical needs.
Oxis International Inc. Announces Request for Euronext Trading Suspension
PR Newswire - Tue Mar 31, 8:07AM CDT
Oxis International, Inc. (OXIS) (OXI.PA) a biotechnology company focused on biotech cancer therapy development and commercialization, announced today Oxis CEO Tony Cataldo has requested a suspension of the trading of Oxis common shares on the Euronext exchange. Oxis shares will continue to trade on the OTCQB under the symbol OXIS.
MarijuanaStocks.com to Host Oxis International (OXIS) Conference Call with CEO Tony Cataldo
ACCESSWIRE - Mon Mar 30, 11:38AM CDT
CORAL GABLES, FL / ACCESSWIRE / March 30, 2015 / MarijuanaStocks.com-Oxis International (OTCQB: OXIS) recently announced that the Company will be holding an investor conference call on Tuesday, March 31, 2015 at 4:15pm EST to discuss recent corporate developments. As a result of receiving emails and social media messages from our loyal followers as to who will be hosting the conference call and how attendees can ask specific questions, MatrijuanaStocks.com reached out to OXIS CEO Tony Cataldo and expressed the amount of interest our followers have in the upcoming conference call.
Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh
PR Newswire - Thu Mar 26, 6:30AM CDT
Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc. [OTC: OXIS] and [Euronext Paris: OXI.PA] announced today the execution of an exclusive option agreement with the University of Pittsburgh related to certain patents/intellectual properties developed by Dr. Xiang-Qun Xie, Associate Dean for Research Innovation and Professor, Pharmaceutical Sciences, School of Pharmacy. These patents/intellectual properties relate to novel compositions-of-matter which could prove useful as therapeutics for the treatment of various human diseases. The term of the exclusive option is eighteen (18) months. During the term of exclusivity, the University of Pittsburgh will not offer third parties the opportunity to license these intellectual properties.
Biotechnology And The Road To Innovation: What Companies Are Pushing New Innovation In Today's Market?
ACCESSWIRE - Thu Mar 19, 8:15AM CDT
CORAL GABLES, FL / ACCESSWIRE / March 19, 2015 / Globally, the market for biotechnology has been growing at a rate of over 10% annually according to a report from IBISWorld. Annual revenue is on the cusp of breaking $290 Billion and has many sub sectors contributing to its further expansion. Industry firms have thrived as technological advances have facilitated new discoveries and ignited higher demand from firms in the pharmaceuticals and agricultural sectors. According to the report, industry growth is forecast to continue "skyrocketing in the next five-year period" where investment in biotechnology from around the world increases, particularly from emerging economies.
Rapidly Rising: Fastfunds Financial Corporation (OTCBB:FFFC)
ACCESSWIRE - Tue Mar 17, 11:55PM CDT
WINDSOR, ON / ACCESSWIRE / March 18, 2015 / The Cannabis Capitalist, an Investment newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known stocks in the new recreational and medical Cannabis industry, would like to announce a new Company which is creating excitement on Wall Street: Fastfunds Financial (OTCBB:FFFC).
CARA: 10.93 (+0.27), GWPH: 91.32 (+0.38)
MultiCell inks R&D agreement with Oxis Biotech
Seeking Alpha - at Seeking Alpha - Fri Mar 13, 12:10PM CDT
Oxis Biotech Licenses Rights To Antibody-Drug Conjugates For The Treatment Of Cancer
PR Newswire - Thu Mar 12, 6:30AM CDT
Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc. [OTC: OXIS] and [Euronext Paris: OXI.PA] announced today the execution of a definitive licensing and development agreement with MultiCell Immunotherapeutics, Inc. (MCIT) concerning the development of certain antibody-drug conjugates (ADCs). These ADCs are thought to be useful for the treatment of triple-negative breast cancer, and multiple myeloma and associated osteolytic lesions which are significant unmet medical needs.
Penny Stocks Trending Alerts for Eventure Interactive, Telupay International, TOTALLY HEMP CRAZY, OXIS International, Monster Arts, and BE ACTIVE HOLDINGS
PR Newswire - Mon Mar 09, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Eventure Interactive (OTCBB:EVTI), Telupay International (OTCMKTS:TLPY), TOTALLY HEMP CRAZY (OTCMKTS:THCZ), OXIS International (OTCMKTS:OXIS), Monster Arts (OTCBB:APPZ), and BE ACTIVE HOLDINGS (OTCMKTS:JALA).
48 Marijuana Stocks - A Post-Mortem: Part II
Anthony Cataldo - at Seeking Alpha - Wed Mar 04, 7:36AM CST
INSY: 57.97 (+0.06), FULL: 3.55 (-0.03), CARA: 10.93 (+0.27)
Top 5 Cannabis Stocks to Watch in 2015
ACCESSWIRE - Wed Feb 11, 8:39AM CST
CORAL GABLES, FL / ACCESSWIRE / February 11, 2015 / It's been a long and rough road for a push toward universal legalization of marijuana in the US. Since the early beginnings in California many decades ago with medical marijuana to the latest trail being blazed from states like Colorado, Oregon, Washington, and Alaska, this has certainly become a growth driven marketplace full of opportunity. It seems like those entering the space are facing the "kid in a candy store" mentality as so many industry assets can be applied to this new sector. From consulting services to biotech, there is a myriad of options for companies to focus on during these early stages. But the question remains, "Are 'pot' stocks really delivering for investors?" So, which stocks should you be in right now?
Oxis Biotech Inc. Provides Update for P62-ZZ Multiple Myeloma Patent Application
PR Newswire - Wed Feb 04, 6:30AM CST
Oxis International, Inc. (OXIS) (OXI.PA) a biotechnology company focused on cannabinoid therapy development and commercialization, provided today an update on its P62-ZZ Chemical Inhibitor and Therapeutic Potential for Multiple Myeloma patent application for shareholders and other interested parties.
Fresh Press Coming From Several Cannabis Related Companies
ACCESSWIRE - Mon Feb 02, 7:30AM CST
MIAMI, FL / ACCESSWIRE / February 2, 2015 / There are many things that can have an impact on share volume. These include speculation, rumors, and actual material events. Over the last week, several cannabis related public companies have made announcements which may or may not have sparked increases in trading activities for Oxis International (OTCQB:OXIS), Electronic Cigarettes International Group, Ltd. (OTCQB:ECIG), and American Green, Inc. (OTC:ERBB).
Are You Cashing In On Cannabis With These Market Movers?
ACCESSWIRE - Thu Jan 29, 9:26AM CST
MIAMI, FL / ACCESSWIRE / January 29, 2015 / The cannabis space is slowly starting to shake off its "dark cloud". The industry is now open to bigger investment, more states have legalized the drug both for medical and recreational use, and even more are putting the wheels in motion for the 2016 ballot. Here are some of the more popular movers in the sector which have been gaining attention in 2015.
This Is Where The Investment Opportunity Is Right Now In Cannabis
Small Cap Reporter - at Seeking Alpha - Tue Jan 20, 11:25AM CST
INSY: 57.97 (+0.06), GWPH: 91.32 (+0.38)
Are These Cannabis Stocks In Your Winning Portfolio Right Now?
ACCESSWIRE - Tue Jan 20, 7:31AM CST
CORAL GABLES, FL / ACCESSWIRE / January 20, 2015 / Medical marijuana has been legalized in 23 states and the District of Columbia. Recreational marijuana is now legal in two states: Colorado and Washington. The market for legalized marijuana will grow by 64% between 2014 and 2015, cites State of Marijuana Markets, "Cannabis is one of the fastest-growing industries," Steve Berg tells The Huffington Post, "domestically, we weren't able to find any market that is growing as quickly."
Cannabusiness Takes Center Stage As Stocks Rally
ACCESSWIRE - Fri Jan 16, 7:51AM CST
CORAL GABLES, FL / ACCESSWIRE / January 16, 2015 / Recreational cannabis, federal government easement on policy, and increase support from the masses has propelled massive industry growth for cannabis companies this year. Investors have found that there have been many opportunities to turn a profit during these very early stages of this industry boom. As the market continues to grow and the hopes of a less risk filled sector arise, investors continue to look for opportunity as more companies join the marijuana revolution. According to MMJ Business Daily, 2015 is expected not only to see more investment dollars flow into the market but it could even outpace the growth rate seen in 2014. The reason? States like Nevada, Illinois, Massachusetts, Oregon, and Alaska have all been identified as industry drivers this year. Furthermore, the rise in "BIG MONEY" from some major investment funds has just started to hit the marijuana sector.
Cannabis Companies Are Back In The Spotlight For 2015 On Surging Volume & Big Announcements
ACCESSWIRE - Thu Jan 15, 7:53AM CST
CORAL GABLES, FL / ACCESSWIRE / January 15, 2015 / The cannabis industry has truly evolved through its first year of legalization. We've seen the good, bad, and ugly put so much pressure on the industry that investors have become incredibly savvy in terms of diligence prior to "jumping in the pool". Once a taboo marketplace is now attracting some major investments. Not only did Paypal co-founder Peter Thiel's Founders Fund invest in the industry but now we're seeing some of the big name, pro-cannabis celebrities continue to break down barriers and put their money into the market. Tommy Chong, the Marley family, and even successful Wall Street investors like George Soros are all putting up the "dough" for full legalization of cannabis in the US. With that, many cannabis companies have found a new momentum stride as the industry may be seeing its second boom.
Oxis Biotech Inc. Announces Appointment of Dr. James J Mulé to Scientific Advisory Board
PR Newswire - Thu Jan 15, 6:30AM CST
Oxis International, Inc. (OXIS) (OXI.PA) a biotechnology company focused on cannabinoid therapy development and commercialization, announced today, Dr. James J Mulé has joined the Scientific Advisory Board for its' wholly owned subsidiary, Oxis Biotech, Inc.
